DWA
KIN

Dorsey Wright & Associates’s Kindred Biosciences, Inc. KIN Stock Holding History

Dorsey Wright & Associates’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,354
Closed -$15K – 345
2018
Q4 		$15K Buy
1,354
+225
+20% +$2.83K ﹤0.01% 205
2018
Q3 		$16K Buy
+1,129
New +$15.3K ﹤0.01% 210

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dorsey Wright & Associates's KIN Position: Q1 2019 in Review

Dorsey Wright & Associates sold out of Kindred Biosciences, Inc. (KIN) in Q1 2019, closing a stake of 1,354 shares — an estimated $15K sold.

Dorsey Wright & Associates first reported a position in KIN in Q3 2018 and held it in 2 quarters. The position peaked at $16K in Q3 2018. 75 funds tracked by Wall St. Rank hold KIN as of Q1 2019.

  • Dorsey Wright & Associates reported no remaining Kindred Biosciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,354 Kindred Biosciences, Inc. shares in Q1 2019, an estimated $15K.
  • Dorsey Wright & Associates first reported a position in Kindred Biosciences, Inc. in Q3 2018 and held it in 2 quarters.
  • Dorsey Wright & Associates's Kindred Biosciences, Inc. position peaked at $16K in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2019.

Based on Dorsey Wright & Associates's 13F filing for Q1 2019, filed 4 Apr 2019.